Cargando…
Identification of Compounds that Rescue IKBKAP Expression in Familial Dysautonomia-iPS Cells
Patient-specific induced pluripotent stem cells (iPSCs) represent a novel system for modeling human genetic disease and could develop into a key drug discovery platform. We recently reported disease-specific phenotypes in iPSCs from familial dysautonomia (FD) patients. FD is a rare but fatal genetic...
Autores principales: | Lee, Gabsang, Ramirez, Christina N., Kim, Hyesoo, Zeltner, Nadja, Liu, Becky, Radu, Constantin, Bhinder, Bhavneet, Kim, Yong Jun, Choi, InYoung, Mukherjee-Clavin, Bipasha, Djaballah, Hakim, Studer, Lorenz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3711177/ https://www.ncbi.nlm.nih.gov/pubmed/23159879 http://dx.doi.org/10.1038/nbt.2435 |
Ejemplares similares
-
Therapeutic manipulation of IKBKAP mis-splicing with a small molecule to cure familial dysautonomia
por: Ajiro, Masahiko, et al.
Publicado: (2021) -
Phosphatidylserine Increases IKBKAP Levels in Familial Dysautonomia Cells
por: Keren, Hadas, et al.
Publicado: (2010) -
Author Correction: Therapeutic manipulation of IKBKAP mis-splicing with a small molecule to cure familial dysautonomia
por: Ajiro, Masahiko, et al.
Publicado: (2021) -
Antisense oligonucleotides correct the familial dysautonomia splicing defect in IKBKAP transgenic mice
por: Sinha, Rahul, et al.
Publicado: (2018) -
Blocking of an intronic splicing silencer completely rescues IKBKAP exon 20 splicing in familial dysautonomia patient cells
por: Bruun, Gitte H, et al.
Publicado: (2018)